Mortality Advantage With Pimavanserin in Parkinson ' s Psychosis? Mortality Advantage With Pimavanserin in Parkinson ' s Psychosis?

Use of pimavanserin was associated with 35% lower mortality for patients with Parkinson ' s disease –related psychosis compared with atypical antipsychotics, a large new real-world analysis shows.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news